FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

32868111000001104: Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100153501000001116 Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100153601000001117 Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Is a Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has active ingredient Paliperidone true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has specific active ingredient Paliperidone palmitate true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form Prolonged-release suspension for injection false Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Paliperidone true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Is a Trevicta true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form Prolonged-release suspension for injection false Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has basis of strength substance Paliperidone true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form Prolonged-release suspension for injection true Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form Prolonged-release suspension for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has AMP True Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start